Ruili Wang
-
- Protease and Inhibitor Mechanisms 2
-
- Parkinson's Disease Mechanisms and Treatments 2
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- Alzheimer's disease research and treatments 2
- Biochemical effects in animals 2
-
- Liver Disease Diagnosis and Treatment 2
- Autophagy in Disease and Therapy 2
-
- Tryptophan and brain disorders 2
- Co-authors
- Ya HeChen LiHui WangYing YangQing LiHong XuZhengwen MaZhongping Cheng
- Partner nations
- China
In The Last Decade
Ruili Wang
21 papers receiving 328 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 94
- Neurology 22
- Internal Medicine 10
- Molecular Biology 165
- Obstetrics and Gynecology 17
Countries citing papers authored by Ruili Wang
This map shows the geographic impact of Ruili Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruili Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruili Wang more than expected).
Fields of papers citing papers by Ruili Wang
This network shows the impact of papers produced by Ruili Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruili Wang. The network helps show where Ruili Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ruili Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 22 | |
| 3 | 2021 | 10 | |
| 4 | 2021 | 15 | |
| 5 | 2020 | 10 | |
| 6 | 2020 | 7 | |
| 7 | 2020 | 56 | |
| 8 | 2020 | 5 | |
| 9 | 2019 | 8 | |
| 10 | 2019 | 25 | |
| 11 | 2019 | 11 | |
| 12 | 2019 | 47 | |
| 13 | 2018 | 22 | |
| 14 | 2017 | 5 | |
| 15 | 2016 | 14 | |
| 16 | 2015 | 5 | |
| 17 | 2011 | 21 | |
| 18 | 2010 | 27 | |
| 19 | [Study on the status of cognition among Parkinson's disease patients in Xi'an.]. | 2010 | 1 |
| 20 | [Relationship between the 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and the pathogenesis of pregnancy-induced hypertension syndrome]. | 2004 | 1 |
About Ruili Wang
Ruili Wang is a scholar working on Biological Psychiatry, Hematology and Physiology, having authored 22 papers that have together received 331 indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (3 papers), Alzheimer's disease research and treatments (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Autophagy in Disease and Therapy (2 papers), Tryptophan and brain disorders (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Biochemical effects in animals (2 papers). The work is most often cited by research in Cancer Research (94 citations), Neurology (22 citations) and Internal Medicine (10 citations). Ruili Wang has collaborated with scholars based in China. Frequent co-authors include Ya He, Chen Li, Hui Wang, Ying Yang, Qing Li, Ying Yang, Hong Xu, Zhengwen Ma, Zhongping Cheng and Ying Wang. Their work appears in journals such as Medicine, Gynecologic Oncology and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.